生物源
mouse
抗體表格
purified antibody
抗體產品種類
primary antibodies
無性繁殖
D345, monoclonal
物種活性
human
包裝
antibody small pack of 25 μg
技術
ELISA: suitable
flow cytometry: suitable
immunohistochemistry: suitable (paraffin)
inhibition assay: suitable
western blot: suitable
同型
IgG1κ
NCBI登錄號
UniProt登錄號
目標翻譯後修改
unmodified
基因資訊
human ... EDIL3(10085)
一般說明
EGF-like repeat and discoidin I-like domain-containing protein 3 (UniProt: O43854; also known as Developmentally-regulated endothelial cell locus 1 protein, Integrin-binding protein DEL1, Del-1) is encoded by the EDIL3 (also known as DEL1) gene (Gene ID: 10085) in human. Del-1 is a calcium-dependent glycoprotein that is secreted by endothelial cells and is shown to be expressed in a developmentally restricted pattern during embryogenesis. In adult tissues it is expressed in endothelial cells and in macrophages. Del-1 is reported to prevent apoptosis in endothelial cell subjected to TNF alpha, etoposide, and anoikis treatment. This anti-apoptotic effect is shown to be mediated specifically through binding of integrin alphav beta3 by the RGD motif. Del-1 expression is reported to be inversely related to that of IL-17 that is shown to inhibit Del-1 via a GSK-3beta and C/EBPb-dependent mechanism. This inhibitory action can be reversed at the PI3K/Akt signaling induced by D-resolvins. It serves as an endothelial cell-secreted homeostatic factor that regulates local inflammation in several tissues. It is reported to interfere with beta2-integrin-dependent inflammatory cell adhesion to endothelium and restricts transendothelial migration of neutrophils. Del-1 is synthesized with a signal peptide (aa 1-23), which is subsequently cleaved off in the mature form. It has three EGF-like domains in its N-terminal region. EGF-like domains 2 and 3 form a rigid rod via an interdomain calcium ion binding site, while the long linker between EGF1 and EGF2 lends considerable flexibility to EGF1. Del-1 also has discoidin I-like domains at the C-terminal region that mediate its binding to phosphatidylserine. Two isoforms of Del-1 have been described that are produced by alternative splicing. (Ref.: Dasgupta, SK et al. (2012). Circulation 125 (13); 1664-1672; Wang, Z., et al. (2012). Surgery 151(2); 296-305; Maekawa, T et al. (2015). Nat. Commun. DOI: 10.1038/ncomms9272).
特異性
Clone D345 detects human Developmentally-regulated endothelial cell locus 1 protein (Del-1).
免疫原
GST-tagged full length human recombinant Developmentally-regulated endothelial cell locus 1 protein (Del-1).
應用
Detects Del-1 using this Anti-Del-1, clone D345, Cat. No. MABS1976, is a mouse monoclonal antibody that detects Developmentally-regulated endothelial cell locus 1 protein (Del-1) and has been tested for use in ELISA, Flow Cytometry, Immunohistochemistry (Paraffin), Inhibition assay, & Western Blot.
Immunohistochemistry (Paraffin) Analysis: A 1:50 dilution from a representative lot detected Del-1 in human cerebral cortex tissue sections.
ELISA Analysis: A representative lot detected Del-1 in ELISA applications (Dasgupta, S.K., et. al. (2012). Ciculation. 125(13):1664-72; Maekawa, T., et. al. (2015). Nat Commun. 6:8272).
Inhibition Analysis: A representative lot inhibited the uptake of BODIPY-labeled platelet microparticles by endothelium. (Dasgupta, S.K., et. al. (2012). Ciculation. 125(13):1664-72).
Western Blotting Analysis: A representative lot detected Del-1 in Western Blotting applications (Dasgupta, S.K., et. al. (2012). Ciculation. 125(13):1664-72).
Flow Cytometry Analysis: A representative lot detected Del-1 in Flow Cytometry applications (Dasgupta, S.K., et. al. (2012). Ciculation. 125(13):1664-72).
ELISA Analysis: A representative lot detected Del-1 in ELISA applications (Dasgupta, S.K., et. al. (2012). Ciculation. 125(13):1664-72; Maekawa, T., et. al. (2015). Nat Commun. 6:8272).
Inhibition Analysis: A representative lot inhibited the uptake of BODIPY-labeled platelet microparticles by endothelium. (Dasgupta, S.K., et. al. (2012). Ciculation. 125(13):1664-72).
Western Blotting Analysis: A representative lot detected Del-1 in Western Blotting applications (Dasgupta, S.K., et. al. (2012). Ciculation. 125(13):1664-72).
Flow Cytometry Analysis: A representative lot detected Del-1 in Flow Cytometry applications (Dasgupta, S.K., et. al. (2012). Ciculation. 125(13):1664-72).
Research Category
Apoptosis & Cancer
Apoptosis & Cancer
品質
Evaluated by Immunohistochemistry (Paraffin) in human pancreas tissue sections.
Immunohistochemistry (Paraffin) Analysis: A 1:50 dilution of this antibody detected Del-1 in human pancreas tissue sections.
Immunohistochemistry (Paraffin) Analysis: A 1:50 dilution of this antibody detected Del-1 in human pancreas tissue sections.
標靶描述
53.76 kDa calculated.
外觀
Protein G purified
Format: Purified
Purified mouse monoclonal antibody IgG1 in PBS without azide.
儲存和穩定性
Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
其他說明
Concentration: Please refer to lot specific datasheet.
免責聲明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到適合的產品?
試用我們的產品選擇工具.
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
Bone & joint research, 12(12), 734-746 (2023-12-12)
Therapeutic agents that prevent chondrocyte loss, extracellular matrix (ECM) degradation, and osteoarthritis (OA) progression are required. The expression level of epidermal growth factor (EGF)-like repeats and discoidin I-like domains-containing protein 3 (EDIL3) in damaged human cartilage is significantly higher than
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務